Frontlight ResearchEarly access
CompletedNo phase
Bilateral Peribulbar Block for Cataract Surgery
Key facts
- Who runs it
- Tanta University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 50 people enrolled
- Started
- 3 Jun 2025
- Ended
- 30 Aug 2025
- Type of study
- Observational
- Treatments tested
- Bilateral peribulbar block
- Record updated
- 24 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Age ≥ 18 years
- Both sexes
- American Society of Anesthesiology (ASA) physical status I-III
- Patients undergoing cataract surgery
Who cannot take part
- Previously operated eyes
- Infection at the site of the surgery
- Allergy to any of the used drugs
- Co-existing inflammatory conditions of eye
- Coagulopathy
- Posterior staphyloma
- Bronchial asthma
- Bradyarrhythmia
- Pre-existing ocular muscle paresis
- Neurological deficit
- Complicated cataracts
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to evaluate the safety and efficacy of bilateral peribulbar block for cataract surgery.
The group in the trial
- Peribulbar anesthesia group
Patients undergoing bilateral peribulbar anesthesia for cataract surgery
Treatment: Bilateral peribulbar block
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Safety and Efficacy of Bilateral Peribulbar Block for Cataract Surgery
- Record updated
- 24 April 2026